Gainesville, Fla. - One medication approved for gum disease appears to be effective against moderate facial acne at sub-antimicrobial doses given over six months.
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Indoor Tanning and Melanoma
Skin Barrier 101: Keep Up with What Your Patients Are Reading
2 Clarke Drive Cranbury, NJ 08512